Identification of a Novel Drug Lead That Inhibits HCV Infection and Cell-to-Cell Transmission by Targeting the HCV E2 Glycoprotein-Reference-Cited by-同舟云学术

Identification of a Novel Drug Lead That Inhibits HCV Infection and Cell-to-Cell Transmission by Targeting the HCV E2 Glycoprotein

Published:2014-10-30 Issue:10 Volume:9 Page:e111333
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Al Olaby Reem R.,Cocquerel Laurence,Zemla Adam,Saas Laure,Dubuisson Jean,Vielmetter Jost,Marcotrigiano Joseph,Khan Abdul Ghafoor,Catalan Felipe Vences,Perryman Alexander L.,Freundlich Joel S.,Forli Stefano,Levy Shoshana,Balhorn Rod,Azzazy Hassan M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference104 articles.

1. Prevalence of active hepatitis C virus infections among general public of lahore, Pakistan;MI Anwar;Virol J,2013

2. Acute hepatitis C virus infection: A chronic problem;JT Blackard;Hepatology,2008

3. Marks KM, Jacobson IM (2012) The first wave: HCV NS3 protease inhibitors telaprevir and boceprevir. Antivir Ther 17(6 Pt B): 1119–1131. 10.3851/IMP2424; 10.3851/IMP2424.

4. Colombo M, Fernandez I, Abdurakhmanov D, Ferreira PA, Strasser SI, et al. (2013) Safety and on-treatment efficacy of telaprevir: The early access programme for patients with advanced hepatitis C. Gut. 10.1136/gutjnl-2013-305667; 10.1136/gutjnl-2013-305667.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Local and global stability of an HCV viral dynamics model with two routes of infection and adaptive immunity;Computer Methods in Biomechanics and Biomedical Engineering;2023-08-21

2. Targeting of Tetraspanin CD81 with Monoclonal Antibodies and Small Molecules to Combat Cancers and Viral Diseases;Cancers;2023-04-06

3. Methodological Verification-based Screening of the Representative Ingredients for Traditional Chinese Medicine: Taking Astragalus as an Example for Interfering with Cervical Cancer;Current Computer-Aided Drug Design;2022-08

4. Molecular Mechanisms Underlying the Cellular Entry and Host Range Restriction of Lujo Virus;mBio;2022-02-22

5. Targeting hepatocellular carcinoma by small-molecule inhibitors;Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3;2022